| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.775 | 0.003 | 0.775 | Superoxide dismutase inhibitor | 0.742 0.004 DBMET01456 0.605 0.006 DBMET01457 | ||
| 0.757 | 0.005 | 0.757 | 5 Hydroxytryptamine release stimulant | 0.552 0.02 DBMET01456 0.521 0.024 DBMET01457 | ||
| 0.672 | 0.004 | 0.672 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.348 0.029 DBMET01456 | ||
| 0.651 | 0.002 | 0.651 | GABA C receptor agonist | 0.409 0.005 DBMET01456 0.338 0.007 DBMET01457 | ||
| 0.613 | 0.004 | 0.613 | DNA intercalator | 0.339 0.01 DBMET01456 0.241 0.017 DBMET01457 | ||
| 0.593 | 0.004 | 0.593 | Chelator | 0.484 0.005 DBMET01456 0.336 0.009 DBMET01457 | ||
| 0.588 | 0.009 | 0.588 | GABA C receptor rho-3 antagonist | 0.48 0.032 DBMET01456 0.561 0.013 DBMET01457 | ||
| 0.571 | 0.015 | 0.571 | 5 Hydroxytryptamine release inhibitor | 0.487 0.037 DBMET01456 0.454 0.05 DBMET01457 | ||
| 0.55 | 0.004 | 0.55 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.301 0.018 DBMET01456 | ||
| 0.554 | 0.025 | 0.554 | Aldehyde oxidase inhibitor | 0.251 0.082 DBMET01456 0.411 0.045 DBMET01457 | ||
| 0.53 | 0.004 | 0.53 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.354 0.024 DBMET01456 | ||
| 0.516 | 0.005 | 0.516 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.399 0.021 DBMET01456 0.276 0.083 DBMET01457 | ||
| 0.502 | 0.004 | 0.536 | Peptidyltransferase inhibitor | 0.531 0.003 DBMET01456 0.536 0.003 DBMET01457 | DBMET01457 | |
| 0.471 | 0.004 | 0.471 | Tyrosine 3 hydroxylase inhibitor | 0.423 0.006 DBMET01456 0.453 0.005 DBMET01457 | ||
| 0.5 | 0.034 | 0.52 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.464 0.052 DBMET01456 0.52 0.025 DBMET01457 | DBMET01457 | |
| 0.473 | 0.012 | 0.473 | Peroxidase inhibitor | 0.355 0.027 DBMET01456 0.398 0.021 DBMET01457 | ||
| 0.459 | 0.006 | 0.763 | Alpha-N-acetylglucosaminidase inhibitor | 0.597 0.004 DBMET01456 0.763 0.002 DBMET01457 | DBMET01457 | |
| 0.454 | 0.006 | 0.454 | Protein kinase C nu inhibitor | 0.268 0.031 DBMET01456 | ||
| 0.445 | 0.008 | 0.445 | 5 Hydroxytryptamine uptake stimulant | 0.329 0.032 DBMET01456 0.353 0.024 DBMET01457 | ||
| 0.447 | 0.011 | 0.447 | Death-associated protein kinase 3 inhibitor | 0.282 0.043 DBMET01456 | ||
| 0.453 | 0.02 | 0.453 | Cardiotonic | 0.281 0.065 DBMET01456 0.341 0.042 DBMET01457 | ||
| 0.428 | 0.013 | 0.428 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.218 0.056 DBMET01456 | ||
| 0.418 | 0.004 | 0.418 | Death-associated protein kinase 2 inhibitor | 0.297 0.007 DBMET01456 0.177 0.058 DBMET01457 | ||
| 0.417 | 0.014 | 0.417 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.229 0.059 DBMET01456 | ||
| 0.43 | 0.027 | 0.43 | Vasodilator, coronary | 0.387 0.039 DBMET01456 0.368 0.047 DBMET01457 | ||
| 0.401 | 0.005 | 0.401 | Protein kinase A inhibitor | 0.173 0.019 DBMET01456 | ||
| 0.4 | 0.004 | 0.4 | Protein kinase B gamma inhibitor | 0.201 0.008 DBMET01456 | ||
| 0.385 | 0.003 | 0.385 | GABA C receptor antagonist | 0.235 0.008 DBMET01456 0.203 0.012 DBMET01457 | ||
| 0.4 | 0.025 | 0.4 | Calcium channel activator | 0.296 0.096 DBMET01456 0.33 0.064 DBMET01457 | ||
| 0.402 | 0.028 | 0.402 | DNA damaging | 0.307 0.054 DBMET01456 0.246 0.082 DBMET01457 | ||
| 0.384 | 0.012 | 0.384 | Phospholipase C inhibitor | 0.342 0.015 DBMET01456 0.293 0.019 DBMET01457 | ||
| 0.375 | 0.004 | 0.375 | Alcohol oxidase inhibitor | 0.316 0.004 DBMET01456 0.228 0.005 DBMET01457 | ||
| 0.415 | 0.05 | 0.415 | MAP kinase kinase 6 inhibitor | |||
| 0.362 | 0.004 | 0.362 | CXC chemokine 4 receptor antagonist | 0.223 0.009 DBMET01456 0.106 0.023 DBMET01457 | ||
| 0.356 | 0.004 | 0.356 | I kappa B kinase 1 inhibitor | 0.192 0.006 DBMET01456 | ||
| 0.352 | 0.004 | 0.352 | MAP kinase kinase 3 inhibitor | 0.27 0.017 DBMET01456 0.254 0.028 DBMET01457 | ||
| 0.345 | 0.003 | 0.345 | 5 Hydroxytryptamine 3E antagonist | 0.295 0.005 DBMET01456 0.292 0.005 DBMET01457 | ||
| 0.363 | 0.028 | 0.363 | DNA synthesis inhibitor | 0.312 0.04 DBMET01456 0.336 0.033 DBMET01457 | ||
| 0.357 | 0.022 | 0.357 | Growth hormone agonist | 0.325 0.028 DBMET01456 0.185 0.065 DBMET01457 | ||
| 0.371 | 0.037 | 0.38 | Interleukin 2 agonist | 0.38 0.034 DBMET01456 0.314 0.064 DBMET01457 | DBMET01456 | |
| 0.338 | 0.005 | 0.338 | Ferrochelatase inhibitor | 0.302 0.007 DBMET01456 0.332 0.005 DBMET01457 | ||
| 0.405 | 0.075 | 0.45 | Antibacterial | 0.45 0.057 DBMET01456 0.37 0.091 DBMET01457 | DBMET01456 | |
| 0.356 | 0.03 | 0.396 | Psychostimulant | 0.396 0.023 DBMET01456 0.386 0.025 DBMET01457 | DBMET01456 | |
| 0.324 | 0.005 | 0.324 | Protein kinase C mu inhibitor | 0.162 0.021 DBMET01456 | ||
| 0.323 | 0.005 | 0.323 | Telomerase inhibitor | 0.18 0.016 DBMET01456 0.105 0.031 DBMET01457 | ||
| 0.324 | 0.006 | 0.327 | Carbonic anhydrase XV inhibitor | 0.327 0.006 DBMET01456 0.234 0.014 DBMET01457 | DBMET01456 | |
| 0.319 | 0.003 | 0.319 | Somatostatin 5 agonist | 0.112 0.004 DBMET01456 0.031 0.03 DBMET01457 | ||
| 0.347 | 0.035 | 0.369 | Insulysin inhibitor | 0.369 0.028 DBMET01456 0.367 0.029 DBMET01457 | DBMET01456 | |
| 0.384 | 0.084 | 0.463 | Histamine release inhibitor | 0.407 0.072 DBMET01456 0.463 0.044 DBMET01457 | DBMET01457 | |
| 0.306 | 0.007 | 0.397 | Histone deacetylase SIRT1 inhibitor | 0.397 0.004 DBMET01456 0.33 0.005 DBMET01457 | DBMET01456 | |
| 0.326 | 0.027 | 0.326 | MAP kinase kinase 2 inhibitor | 0.277 0.043 DBMET01456 0.218 0.071 DBMET01457 | ||
| 0.331 | 0.035 | 0.396 | Interleukin agonist | 0.396 0.019 DBMET01456 0.387 0.021 DBMET01457 | DBMET01456 | |
| 0.299 | 0.003 | 0.299 | GABA C receptor rho-1 antagonist | 0.203 0.008 DBMET01456 0.184 0.011 DBMET01457 | ||
| 0.313 | 0.023 | 0.313 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.301 | 0.012 | 0.301 | Cyclin-dependent kinase 7 inhibitor | 0.175 0.044 DBMET01456 | ||
| 0.301 | 0.013 | 0.301 | Antiadrenergic | 0.157 0.034 DBMET01457 | ||
| 0.298 | 0.012 | 0.298 | Nitric-oxide synthase stimulant | 0.242 0.038 DBMET01456 0.275 0.019 DBMET01457 | ||
| 0.291 | 0.005 | 0.291 | Porphobilinogen synthase inhibitor | 0.209 0.011 DBMET01456 0.193 0.013 DBMET01457 | ||
| 0.299 | 0.014 | 0.299 | Adenylate cyclase inhibitor | 0.246 0.019 DBMET01456 0.183 0.029 DBMET01457 | ||
| 0.29 | 0.004 | 0.29 | Nitric-oxide synthase inhibitor | 0.195 0.01 DBMET01456 0.136 0.029 DBMET01457 | ||
| 0.349 | 0.065 | 0.405 | Immunostimulant | 0.405 0.048 DBMET01456 0.378 0.056 DBMET01457 | DBMET01456 | |
| 0.284 | 0.003 | 0.284 | Kinesin antagonist | 0.152 0.005 DBMET01456 | ||
| 0.284 | 0.003 | 0.284 | Kinesin-like protein 1 inhibitor | 0.152 0.005 DBMET01456 | ||
| 0.291 | 0.014 | 0.291 | Adrenaline antagonist | 0.152 0.034 DBMET01457 | ||
| 0.287 | 0.013 | 0.287 | Alkylator | 0.22 0.021 DBMET01456 0.182 0.032 DBMET01457 | ||
| 0.292 | 0.019 | 0.292 | Topoisomerase II inhibitor | 0.152 0.049 DBMET01456 0.125 0.063 DBMET01457 | ||
| 0.281 | 0.008 | 0.281 | Topoisomerase II alpha inhibitor | 0.173 0.019 DBMET01456 0.183 0.018 DBMET01457 | ||
| 0.277 | 0.007 | 0.277 | Aminoacyl-tRNA synthetase inhibitor | 0.147 0.02 DBMET01456 | ||
| 0.272 | 0.004 | 0.272 | Adenylate cyclase stimulant | 0.227 0.006 DBMET01456 0.203 0.012 DBMET01457 | ||
| 0.272 | 0.004 | 0.272 | Somatostatin agonist | 0.064 0.01 DBMET01456 | ||
| 0.268 | 0.005 | 0.268 | Inducible nitric-oxide synthase inhibitor | 0.155 0.015 DBMET01456 0.1 0.037 DBMET01457 | ||
| 0.292 | 0.029 | 0.292 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.199 0.077 DBMET01456 | ||
| 0.381 | 0.122 | 0.404 | Caspase 9 stimulant | 0.322 0.171 DBMET01456 0.404 0.109 DBMET01457 | DBMET01457 | |
| 0.285 | 0.027 | 0.305 | Neuropeptide Y2 antagonist | 0.305 0.017 DBMET01456 0.288 0.025 DBMET01457 | DBMET01456 | |
| 0.259 | 0.004 | 0.259 | Protein kinase C iota inhibitor | 0.134 0.011 DBMET01456 | ||
| 0.274 | 0.028 | 0.274 | Thrombolytic | 0.222 0.042 DBMET01456 0.125 0.104 DBMET01457 | ||
| 0.295 | 0.05 | 0.295 | Vasodilator | 0.246 0.071 DBMET01456 0.2 0.105 DBMET01457 | ||
| 0.248 | 0.005 | 0.248 | 5 Hydroxytryptamine 3A agonist | 0.144 0.039 DBMET01456 0.132 0.046 DBMET01457 | ||
| 0.251 | 0.01 | 0.251 | Adenylate kinase inhibitor | 0.192 0.016 DBMET01456 0.213 0.013 DBMET01457 | ||
| 0.248 | 0.009 | 0.248 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.248 | 0.009 | 0.248 | Histidine decarboxylase inhibitor | 0.14 0.021 DBMET01456 0.11 0.028 DBMET01457 | ||
| 0.286 | 0.048 | 0.286 | Amyloid beta aggregation inhibitor | 0.215 0.07 DBMET01456 0.216 0.07 DBMET01457 | ||
| 0.242 | 0.004 | 0.242 | Somatostatin 1 agonist | 0.18 0.009 DBMET01456 0.089 0.042 DBMET01457 | ||
| 0.246 | 0.013 | 0.246 | GABA C receptor rho-2 antagonist | 0.179 0.043 DBMET01456 0.233 0.015 DBMET01457 | ||
| 0.247 | 0.016 | 0.247 | Cell wall synthesis inhibitor | 0.247 0.017 DBMET01456 0.217 0.024 DBMET01457 | ||
| 0.254 | 0.024 | 0.254 | Acetylcholine M1 receptor antagonist | 0.211 0.038 DBMET01456 0.183 0.05 DBMET01457 | ||
| 0.251 | 0.022 | 0.251 | Succinate dehydrogenase inhibitor | 0.214 0.039 DBMET01456 0.241 0.026 DBMET01457 | ||
| 0.275 | 0.049 | 0.275 | 5 Hydroxytryptamine 1E antagonist | 0.239 0.087 DBMET01456 0.256 0.069 DBMET01457 | ||
| 0.309 | 0.09 | 0.324 | Transcription factor NF kappa B inhibitor | 0.324 0.084 DBMET01456 0.311 0.089 DBMET01457 | DBMET01456 | |
| 0.22 | 0.005 | 0.22 | Myeloperoxidase inhibitor | 0.189 0.006 DBMET01456 0.13 0.016 DBMET01457 | ||
| 0.218 | 0.009 | 0.222 | Glutamate dehydrogenase inhibitor | 0.222 0.008 DBMET01456 0.193 0.01 DBMET01457 | DBMET01456 | |
| 0.215 | 0.006 | 0.215 | Ornithine carbamoyltransferase inhibitor | 0.16 0.009 DBMET01456 0.129 0.012 DBMET01457 | ||
| 0.211 | 0.006 | 0.211 | Phenylalanine 4-hydroxylase inhibitor | 0.146 0.012 DBMET01456 0.123 0.017 DBMET01457 | ||
| 0.229 | 0.025 | 0.25 | Neurotensin receptor agonist | 0.25 0.021 DBMET01456 0.238 0.023 DBMET01457 | DBMET01456 | |
| 0.231 | 0.027 | 0.231 | Interleukin 6 antagonist | 0.154 0.084 DBMET01456 | ||
| 0.218 | 0.018 | 0.218 | Aminopeptidase B inhibitor | 0.207 0.02 DBMET01456 0.19 0.024 DBMET01457 | ||
| 0.244 | 0.045 | 0.244 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.18 0.093 DBMET01456 0.204 0.068 DBMET01457 | ||
| 0.21 | 0.012 | 0.21 | Carbonic anhydrase VI inhibitor | 0.183 0.015 DBMET01456 0.129 0.026 DBMET01457 | ||
| 0.27 | 0.074 | 0.337 | Transcription factor STAT inhibitor | 0.32 0.045 DBMET01456 0.337 0.039 DBMET01457 | DBMET01457 | |
| 0.275 | 0.08 | 0.275 | Spasmolytic | 0.212 0.11 DBMET01456 0.269 0.083 DBMET01457 | ||
| 0.199 | 0.009 | 0.199 | Protein kinase C delta inhibitor | 0.105 0.048 DBMET01456 | ||
| 0.206 | 0.016 | 0.206 | Check point kinase 2 inhibitor | 0.086 0.078 DBMET01456 | ||
| 0.199 | 0.009 | 0.199 | Check point kinase 1 inhibitor | |||
| 0.225 | 0.036 | 0.225 | Diuretic | 0.223 0.036 DBMET01456 0.209 0.041 DBMET01457 | ||
| 0.191 | 0.006 | 0.208 | Acyl-CoA dehydrogenase inhibitor | 0.192 0.006 DBMET01456 0.208 0.005 DBMET01457 | DBMET01457 | |
| 0.209 | 0.024 | 0.209 | Topoisomerase I inhibitor | |||
| 0.232 | 0.048 | 0.232 | LIM domain kinase 1 inhibitor | 0.186 0.07 DBMET01456 0.14 0.108 DBMET01457 | ||
| 0.252 | 0.069 | 0.311 | Angiogenesis stimulant | 0.311 0.045 DBMET01456 0.282 0.056 DBMET01457 | DBMET01456 | |
| 0.238 | 0.056 | 0.238 | Anesthetic general | 0.189 0.081 DBMET01456 0.213 0.068 DBMET01457 | ||
| 0.19 | 0.008 | 0.19 | Glutamate decarboxylase inhibitor | 0.137 0.016 DBMET01456 0.118 0.022 DBMET01457 | ||
| 0.199 | 0.019 | 0.199 | Neuropeptide Y1 antagonist | 0.186 0.025 DBMET01456 0.183 0.027 DBMET01457 | ||
| 0.195 | 0.015 | 0.195 | Protein kinase C gamma inhibitor | 0.153 0.03 DBMET01456 0.118 0.054 DBMET01457 | ||
| 0.182 | 0.005 | 0.215 | Glutamate (mGluR7) agonist | 0.183 0.005 DBMET01456 0.215 0.004 DBMET01457 | DBMET01457 | |
| 0.256 | 0.079 | 0.338 | Transcription factor STAT3 inhibitor | 0.311 0.048 DBMET01456 0.338 0.037 DBMET01457 | DBMET01457 | |
| 0.207 | 0.031 | 0.207 | Anesthetic local | 0.154 0.047 DBMET01456 0.203 0.032 DBMET01457 | ||
| 0.235 | 0.06 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.18 0.133 DBMET01456 0.213 0.082 DBMET01457 | ||
| 0.178 | 0.005 | 0.178 | Protein kinase C eta inhibitor | 0.097 0.018 DBMET01456 | ||
| 0.197 | 0.023 | 0.197 | CF transmembrane conductance regulator agonist | 0.145 0.085 DBMET01456 0.167 0.051 DBMET01457 | ||
| 0.188 | 0.016 | 0.251 | Mucolytic | 0.242 0.007 DBMET01456 0.251 0.006 DBMET01457 | DBMET01457 | |
| 0.179 | 0.009 | 0.179 | Carbamoyl phosphate synthetase inhibitor | 0.107 0.019 DBMET01456 0.113 0.017 DBMET01457 | ||
| 0.182 | 0.012 | 0.182 | NADH dehydrogenase inhibitor | 0.113 0.033 DBMET01456 0.144 0.019 DBMET01457 | ||
| 0.18 | 0.01 | 0.18 | CYP2A6 inhibitor | 0.075 0.053 DBMET01456 | ||
| 0.187 | 0.018 | 0.198 | Carbonic anhydrase III inhibitor | 0.198 0.017 DBMET01456 0.148 0.029 DBMET01457 | DBMET01456 | |
| 0.182 | 0.013 | 0.182 | Triose-phosphate isomerase inhibitor | 0.127 0.029 DBMET01456 0.158 0.018 DBMET01457 | ||
| 0.234 | 0.068 | 0.573 | Interleukin antagonist | 0.573 0.014 DBMET01456 0.55 0.016 DBMET01457 | DBMET01456 | |
| 0.171 | 0.005 | 0.171 | Protein kinase C epsilon inhibitor | 0.123 0.009 DBMET01456 | ||
| 0.179 | 0.014 | 0.179 | Creatine kinase inhibitor | 0.124 0.038 DBMET01456 0.146 0.026 DBMET01457 | ||
| 0.185 | 0.021 | 0.185 | Bronchodilator | 0.108 0.055 DBMET01456 0.168 0.025 DBMET01457 | ||
| 0.186 | 0.024 | 0.271 | Histone deacetylase class III inhibitor | 0.271 0.008 DBMET01456 0.231 0.012 DBMET01457 | DBMET01456 | |
| 0.273 | 0.112 | 0.409 | Vasodilator, peripheral | 0.245 0.131 DBMET01456 0.409 0.052 DBMET01457 | DBMET01457 | |
| 0.18 | 0.019 | 0.194 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.154 0.025 DBMET01456 0.194 0.017 DBMET01457 | DBMET01457 | |
| 0.161 | 0.007 | 0.176 | NMDA receptor agonist | 0.176 0.005 DBMET01456 0.154 0.008 DBMET01457 | DBMET01456 | |
| 0.173 | 0.019 | 0.173 | Sphingosine 1-phosphate receptor 2 antagonist | 0.152 0.038 DBMET01456 0.173 0.019 DBMET01457 | ||
| 0.174 | 0.021 | 0.174 | Interleukin 8 antagonist | 0.164 0.026 DBMET01456 0.139 0.042 DBMET01457 | ||
| 0.159 | 0.006 | 0.159 | GABA aminotransferase inhibitor | 0.113 0.019 DBMET01456 0.1 0.027 DBMET01457 | ||
| 0.161 | 0.008 | 0.182 | Histamine H2 receptor antagonist | 0.182 0.006 DBMET01456 0.154 0.009 DBMET01457 | DBMET01456 | |
| 0.204 | 0.051 | 0.204 | Anticoagulant | 0.15 0.081 DBMET01456 | ||
| 0.181 | 0.029 | 0.21 | Cathepsin H inhibitor | 0.206 0.021 DBMET01456 0.21 0.02 DBMET01457 | DBMET01457 | |
| 0.173 | 0.022 | 0.173 | Vanilloid 1 agonist | 0.169 0.024 DBMET01456 0.157 0.032 DBMET01457 | ||
| 0.162 | 0.01 | 0.162 | Histamine N-methyltransferase inhibitor | 0.096 0.05 DBMET01456 0.081 0.065 DBMET01457 | ||
| 0.233 | 0.082 | 0.303 | Calpain inhibitor | 0.275 0.045 DBMET01456 0.303 0.029 DBMET01457 | DBMET01457 | |
| 0.171 | 0.021 | 0.191 | Photosensitizer | 0.18 0.018 DBMET01456 0.191 0.015 DBMET01457 | DBMET01457 | |
| 0.16 | 0.01 | 0.16 | Argininosuccinate synthase inhibitor | 0.092 0.021 DBMET01456 0.099 0.019 DBMET01457 | ||
| 0.172 | 0.023 | 0.266 | UDP-glucose 4-epimerase inhibitor | 0.163 0.025 DBMET01456 0.266 0.012 DBMET01457 | DBMET01457 | |
| 0.166 | 0.018 | 0.185 | Sphingomyelinase inhibitor | 0.169 0.017 DBMET01456 0.185 0.013 DBMET01457 | DBMET01457 | |
| 0.152 | 0.005 | 0.152 | Histamine agonist | 0.086 0.012 DBMET01456 0.063 0.025 DBMET01457 | ||
| 0.239 | 0.092 | 0.26 | Gastrin inhibitor | 0.19 0.165 DBMET01456 0.26 0.068 DBMET01457 | DBMET01457 | |
| 0.155 | 0.008 | 0.155 | Protein kinase B alpha inhibitor | |||
| 0.158 | 0.012 | 0.158 | Toll-Like receptor 3 antagonist | 0.088 0.074 DBMET01456 | ||
| 0.157 | 0.011 | 0.162 | Aminopeptidase I inhibitor | 0.156 0.012 DBMET01456 0.162 0.011 DBMET01457 | DBMET01457 | |
| 0.179 | 0.034 | 0.206 | Toll-Like receptor 2 antagonist | 0.204 0.022 DBMET01456 0.206 0.021 DBMET01457 | DBMET01457 | |
| 0.147 | 0.004 | 0.147 | AMPA 2 receptor antagonist | 0.057 0.01 DBMET01456 0.027 0.023 DBMET01457 | ||
| 0.189 | 0.046 | 0.189 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.159 | 0.016 | 0.159 | Phosphofructokinase-1 inhibitor | 0.093 0.035 DBMET01456 0.112 0.028 DBMET01457 | ||
| 0.146 | 0.004 | 0.146 | Endothelial nitric-oxide synthase inhibitor | 0.05 0.009 DBMET01456 0.03 0.022 DBMET01457 | ||
| 0.186 | 0.045 | 0.186 | MAO inhibitor | 0.13 0.069 DBMET01456 | ||
| 0.143 | 0.004 | 0.143 | GHS receptor agonist | 0.058 0.014 DBMET01456 | ||
| 0.142 | 0.004 | 0.142 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.105 0.01 DBMET01456 0.097 0.016 DBMET01457 | ||
| 0.166 | 0.028 | 0.166 | Nav1.4 sodium channel blocker | 0.13 0.044 DBMET01456 | ||
| 0.148 | 0.01 | 0.148 | Biliverdin reductase inhibitor | 0.105 0.017 DBMET01456 0.12 0.014 DBMET01457 | ||
| 0.147 | 0.009 | 0.147 | Carbonic anhydrase VB inhibitor | 0.129 0.011 DBMET01456 0.095 0.017 DBMET01457 | ||
| 0.141 | 0.004 | 0.141 | Growth hormone releasing factor agonist | 0.084 0.005 DBMET01456 0.037 0.02 DBMET01457 | ||
| 0.16 | 0.024 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.14 0.072 DBMET01456 0.155 0.031 DBMET01457 | ||
| 0.137 | 0.004 | 0.137 | Epithelial sodium channel blocker | 0.12 0.005 DBMET01456 0.093 0.008 DBMET01457 | ||
| 0.152 | 0.02 | 0.152 | Toll-Like receptor 4 antagonist | 0.125 0.039 DBMET01456 | ||
| 0.137 | 0.005 | 0.137 | GABA B receptor agonist | 0.107 0.012 DBMET01456 0.097 0.019 DBMET01457 | ||
| 0.149 | 0.017 | 0.149 | MAP kinase kinase 1 inhibitor | 0.122 0.033 DBMET01456 0.109 0.046 DBMET01457 | ||
| 0.168 | 0.036 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.143 0.073 DBMET01456 0.16 0.046 DBMET01457 | ||
| 0.202 | 0.071 | 0.23 | Insulin sensitizer | 0.214 0.06 DBMET01456 0.23 0.047 DBMET01457 | DBMET01457 | |
| 0.141 | 0.01 | 0.141 | Neurotensin receptor antagonist | 0.078 0.018 DBMET01456 | ||
| 0.168 | 0.037 | 0.253 | Nav1.3 sodium channel blocker | 0.191 0.028 DBMET01456 0.253 0.014 DBMET01457 | DBMET01457 | |
| 0.168 | 0.037 | 0.168 | Nav1.6 sodium channel blocker | 0.126 0.087 DBMET01456 0.15 0.054 DBMET01457 | ||
| 0.151 | 0.022 | 0.151 | Transcription factor STAT6 inhibitor | 0.151 0.023 DBMET01456 0.144 0.028 DBMET01457 | ||
| 0.14 | 0.012 | 0.14 | CXC chemokine receptor antagonist | |||
| 0.159 | 0.032 | 0.23 | Expectorant | 0.214 0.018 DBMET01456 0.23 0.015 DBMET01457 | DBMET01457 | |
| 0.164 | 0.037 | 0.164 | Acetylcholine muscarinic antagonist | 0.134 0.054 DBMET01456 0.133 0.055 DBMET01457 | ||
| 0.143 | 0.016 | 0.143 | Adrenaline agonist | 0.088 0.048 DBMET01456 0.116 0.027 DBMET01457 | ||
| 0.213 | 0.088 | 0.213 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.157 | 0.032 | 0.165 | Heat shock protein 70 antagonist | 0.161 0.027 DBMET01456 0.165 0.022 DBMET01457 | DBMET01457 | |
| 0.146 | 0.021 | 0.146 | Electrolyte absorption antagonist | 0.106 0.049 DBMET01456 0.144 0.022 DBMET01457 | ||
| 0.149 | 0.025 | 0.149 | NMDA receptor antagonist | 0.113 0.039 DBMET01456 0.092 0.052 DBMET01457 | ||
| 0.202 | 0.078 | 0.202 | DNA methylase inhibitor | 0.146 0.121 DBMET01456 0.187 0.088 DBMET01457 | ||
| 0.127 | 0.004 | 0.127 | MAP kinase kinase 7 inhibitor | 0.103 0.011 DBMET01456 0.091 0.022 DBMET01457 | ||
| 0.137 | 0.014 | 0.137 | Glutamate release inhibitor | 0.098 0.047 DBMET01456 0.102 0.039 DBMET01457 | ||
| 0.144 | 0.021 | 0.144 | Protein kinase C zeta inhibitor | 0.089 0.067 DBMET01456 | ||
| 0.14 | 0.017 | 0.14 | Carbonic anhydrase V inhibitor | 0.13 0.019 DBMET01456 0.104 0.026 DBMET01457 | ||
| 0.142 | 0.019 | 0.142 | Rho-associated kinase II inhibitor | |||
| 0.125 | 0.003 | 0.125 | Adenylate cyclase 1 inhibitor | 0.098 0.004 DBMET01456 0.097 0.004 DBMET01457 | ||
| 0.146 | 0.024 | 0.146 | Prolactin inhibitor | 0.093 0.063 DBMET01456 0.123 0.036 DBMET01457 | ||
| 0.166 | 0.045 | 0.166 | Toll-Like receptor antagonist | 0.116 0.092 DBMET01456 | ||
| 0.16 | 0.04 | 0.216 | Cyclooxygenase 3 inhibitor | 0.201 0.018 DBMET01456 0.216 0.014 DBMET01457 | DBMET01457 | |
| 0.247 | 0.127 | 0.259 | Cholesterol antagonist | 0.259 0.119 DBMET01457 | DBMET01457 | |
| 0.136 | 0.016 | 0.136 | Ornithine decarboxylase inhibitor | 0.11 0.034 DBMET01456 0.1 0.044 DBMET01457 | ||
| 0.175 | 0.056 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.136 0.094 DBMET01456 | ||
| 0.167 | 0.048 | 0.167 | Nav1.2 sodium channel blocker | 0.146 0.059 DBMET01456 0.155 0.054 DBMET01457 | ||
| 0.135 | 0.019 | 0.135 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.085 0.055 DBMET01456 | ||
| 0.144 | 0.027 | 0.154 | Catalase inhibitor | 0.115 0.034 DBMET01456 0.154 0.025 DBMET01457 | DBMET01457 | |
| 0.192 | 0.076 | 0.192 | Focal adhesion kinase 2 inhibitor | 0.149 0.132 DBMET01457 | ||
| 0.142 | 0.026 | 0.142 | DOPA decarboxylase inhibitor | 0.103 0.07 DBMET01456 0.111 0.057 DBMET01457 | ||
| 0.126 | 0.013 | 0.126 | Protein kinase B beta inhibitor | |||
| 0.118 | 0.005 | 0.118 | Tryptase inhibitor | 0.051 0.012 DBMET01456 0.037 0.026 DBMET01457 | ||
| 0.16 | 0.047 | 0.16 | Cholinergic antagonist | 0.116 0.078 DBMET01456 0.116 0.078 DBMET01457 | ||
| 0.117 | 0.004 | 0.117 | AMPA 4 receptor antagonist | 0.094 0.005 DBMET01456 0.06 0.01 DBMET01457 | ||
| 0.158 | 0.046 | 0.158 | Acetylcholine antagonist | 0.114 0.076 DBMET01456 0.113 0.077 DBMET01457 | ||
| 0.116 | 0.004 | 0.116 | Corticotropin releasing factor 2 receptor antagonist | 0.106 0.005 DBMET01456 0.091 0.01 DBMET01457 | ||
| 0.123 | 0.012 | 0.123 | Glycine receptor agonist | 0.087 0.031 DBMET01456 0.08 0.038 DBMET01457 | ||
| 0.127 | 0.016 | 0.127 | Carbonic anhydrase VA inhibitor | 0.119 0.018 DBMET01456 0.102 0.024 DBMET01457 | ||
| 0.132 | 0.021 | 0.132 | I kappa B kinase inhibitor | 0.11 0.031 DBMET01456 | ||
| 0.113 | 0.005 | 0.113 | Mannosidase inhibitor | 0.067 0.013 DBMET01456 0.058 0.018 DBMET01457 | ||
| 0.13 | 0.022 | 0.13 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.069 DBMET01457 | ||
| 0.114 | 0.007 | 0.114 | Botulinum neurotoxin type A inhibitor | 0.107 0.008 DBMET01456 0.087 0.013 DBMET01457 | ||
| 0.188 | 0.081 | 0.202 | I kappa B kinase epsilon inhibitor | 0.168 0.101 DBMET01456 0.202 0.069 DBMET01457 | DBMET01457 | |
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | 0.094 0.043 DBMET01456 0.111 0.022 DBMET01457 | ||
| 0.113 | 0.007 | 0.113 | Fibroblast growth factor 4 antagonist | 0.06 0.038 DBMET01456 | ||
| 0.109 | 0.004 | 0.109 | Dopamine beta hydroxylase inhibitor | 0.069 0.008 DBMET01456 0.055 0.021 DBMET01457 | ||
| 0.114 | 0.008 | 0.126 | Phospholipase D inhibitor | 0.094 0.018 DBMET01456 0.126 0.005 DBMET01457 | DBMET01457 | |
| 0.111 | 0.006 | 0.111 | Somatostatin 2 antagonist | 0.056 0.013 DBMET01456 | ||
| 0.115 | 0.01 | 0.131 | NMDA receptor glycine site agonist | 0.13 0.006 DBMET01456 0.131 0.006 DBMET01457 | DBMET01457 | |
| 0.151 | 0.047 | 0.151 | Aldehyde dehydrogenase inhibitor | 0.128 0.064 DBMET01456 0.144 0.051 DBMET01457 | ||
| 0.17 | 0.066 | 0.17 | Arachidonic acid antagonist | 0.167 0.068 DBMET01457 | ||
| 0.12 | 0.016 | 0.12 | Protein kinase C alpha inhibitor | 0.061 0.059 DBMET01456 | ||
| 0.107 | 0.004 | 0.107 | Dopamine D5 agonist | 0.052 0.016 DBMET01456 0.047 0.02 DBMET01457 | ||
| 0.116 | 0.013 | 0.116 | Urokinase inhibitor | 0.063 0.027 DBMET01456 | ||
| 0.106 | 0.004 | 0.107 | Histamine H2 receptor agonist | 0.107 0.004 DBMET01456 0.1 0.004 DBMET01457 | DBMET01456 | |
| 0.142 | 0.04 | 0.142 | DNA repair enzyme inhibitor | 0.12 0.072 DBMET01456 0.133 0.051 DBMET01457 | ||
| 0.105 | 0.003 | 0.105 | Parathyroid hormone antagonist | 0.07 0.007 DBMET01456 | ||
| 0.142 | 0.041 | 0.147 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.062 DBMET01456 0.147 0.036 DBMET01457 | DBMET01457 | |
| 0.108 | 0.009 | 0.108 | Heat shock protein 90 beta antagonist | 0.089 0.015 DBMET01456 0.074 0.025 DBMET01457 | ||
| 0.105 | 0.006 | 0.105 | Growth hormone secretagogue receptor agonist | 0.067 0.014 DBMET01456 0.044 0.02 DBMET01457 | ||
| 0.11 | 0.011 | 0.11 | 5 Hydroxytryptamine 2A agonist | 0.057 0.05 DBMET01456 | ||
| 0.113 | 0.015 | 0.113 | Carbonic anhydrase stimulant | 0.103 0.018 DBMET01456 0.094 0.02 DBMET01457 | ||
| 0.102 | 0.004 | 0.102 | Vascular adhesion protein 1 inhibitor | 0.077 0.005 DBMET01456 0.048 0.017 DBMET01457 | ||
| 0.132 | 0.035 | 0.132 | Pim-1 kinase inhibitor | |||
| 0.101 | 0.004 | 0.101 | Diamine oxidase inhibitor | 0.08 0.005 DBMET01456 0.048 0.016 DBMET01457 | ||
| 0.103 | 0.007 | 0.103 | Somatostatin 1 antagonist | 0.064 0.013 DBMET01456 | ||
| 0.103 | 0.006 | 0.103 | Growth hormone release inhibitor | 0.069 0.012 DBMET01456 | ||
| 0.128 | 0.032 | 0.138 | Factor V inhibitor | 0.138 0.025 DBMET01456 0.137 0.025 DBMET01457 | DBMET01456 | |
| 0.138 | 0.042 | 0.138 | MAO B inhibitor | |||
| 0.1 | 0.005 | 0.1 | AMPA 1 receptor antagonist | 0.098 0.005 DBMET01456 0.052 0.01 DBMET01457 | ||
| 0.118 | 0.023 | 0.139 | Hematopoietic | 0.139 0.017 DBMET01456 0.13 0.019 DBMET01457 | DBMET01456 | |
| 0.101 | 0.007 | 0.101 | 5 Hydroxytryptamine 1B agonist | 0.058 0.029 DBMET01456 | ||
| 0.159 | 0.065 | 0.159 | Heat shock protein 90 antagonist | 0.138 0.088 DBMET01456 0.131 0.096 DBMET01457 | ||
| 0.136 | 0.044 | 0.215 | Falcipain 3 inhibitor | 0.183 0.023 DBMET01456 0.215 0.014 DBMET01457 | DBMET01457 | |
| 0.155 | 0.062 | 0.155 | Hemostatic | 0.139 0.083 DBMET01456 0.131 0.094 DBMET01457 | ||
| 0.126 | 0.034 | 0.129 | Anabolic | 0.11 0.049 DBMET01456 0.129 0.032 DBMET01457 | DBMET01457 | |
| 0.127 | 0.035 | 0.127 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.068 DBMET01456 0.098 0.056 DBMET01457 | ||
| 0.103 | 0.011 | 0.103 | I kappa B kinase 2 inhibitor | 0.088 0.017 DBMET01456 0.058 0.052 DBMET01457 | ||
| 0.105 | 0.014 | 0.174 | Toll-Like receptor 2 agonist | 0.174 0.009 DBMET01456 0.159 0.01 DBMET01457 | DBMET01456 | |
| 0.112 | 0.021 | 0.112 | Interferon agonist | 0.097 0.031 DBMET01456 0.105 0.025 DBMET01457 | ||
| 0.098 | 0.007 | 0.098 | Somatostatin 4 agonist | 0.055 0.013 DBMET01456 0.05 0.015 DBMET01457 | ||
| 0.125 | 0.035 | 0.125 | Folate antagonist | 0.09 0.088 DBMET01456 0.093 0.08 DBMET01457 | ||
| 0.253 | 0.162 | 0.253 | 15-Lipoxygenase inhibitor | |||
| 0.099 | 0.01 | 0.099 | Exportin-1 inhibitor | 0.086 0.019 DBMET01456 0.098 0.01 DBMET01457 | ||
| 0.098 | 0.009 | 0.098 | Dipeptidyl peptidase inhibitor | 0.074 0.016 DBMET01456 0.055 0.032 DBMET01457 | ||
| 0.091 | 0.003 | 0.091 | Histamine H1 receptor agonist | 0.069 0.005 DBMET01456 0.063 0.007 DBMET01457 | ||
| 0.101 | 0.013 | 0.101 | Protein kinase C beta inhibitor | 0.077 0.035 DBMET01456 0.07 0.048 DBMET01457 | ||
| 0.193 | 0.105 | 0.207 | Antiamyloidogenic | 0.185 0.111 DBMET01456 0.207 0.095 DBMET01457 | DBMET01457 | |
| 0.097 | 0.009 | 0.097 | Aconitate hydratase inhibitor | 0.052 0.036 DBMET01456 0.059 0.027 DBMET01457 | ||
| 0.102 | 0.015 | 0.102 | Glutamate (mGluR1) antagonist | 0.077 0.025 DBMET01456 0.069 0.031 DBMET01457 | ||
| 0.142 | 0.056 | 0.142 | MAP kinase kinase inhibitor | |||
| 0.1 | 0.014 | 0.1 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.035 DBMET01456 0.079 0.02 DBMET01457 | ||
| 0.164 | 0.079 | 0.164 | Antipruritic | 0.14 0.107 DBMET01457 | ||
| 0.125 | 0.041 | 0.192 | Acetylcholine release stimulant | 0.149 0.017 DBMET01456 0.192 0.005 DBMET01457 | DBMET01457 | |
| 0.113 | 0.029 | 0.113 | Rho-associated kinase inhibitor | |||
| 0.1 | 0.016 | 0.1 | NMDA 2C receptor antagonist | 0.062 0.043 DBMET01456 0.055 0.053 DBMET01457 | ||
| 0.123 | 0.039 | 0.123 | CDC-like kinase 3 inhibitor | 0.109 0.061 DBMET01456 | ||
| 0.088 | 0.005 | 0.088 | Somatostatin 4 antagonist | 0.033 0.01 DBMET01456 | ||
| 0.099 | 0.017 | 0.117 | Beta adrenoreceptor antagonist | 0.093 0.019 DBMET01456 0.117 0.011 DBMET01457 | DBMET01457 | |
| 0.118 | 0.036 | 0.118 | Calcium antagonist | 0.101 0.047 DBMET01457 | ||
| 0.103 | 0.021 | 0.118 | Estrogen-related receptor beta agonist | 0.097 0.029 DBMET01456 0.118 0.011 DBMET01457 | DBMET01457 | |
| 0.09 | 0.009 | 0.09 | Carbonic anhydrase IV inhibitor | 0.083 0.01 DBMET01456 0.075 0.013 DBMET01457 | ||
| 0.089 | 0.008 | 0.089 | Kainate receptor antagonist | 0.058 0.017 DBMET01456 0.043 0.026 DBMET01457 | ||
| 0.085 | 0.004 | 0.085 | Geranyltranstransferase inhibitor | 0.063 0.011 DBMET01456 0.068 0.009 DBMET01457 | ||
| 0.097 | 0.017 | 0.097 | 5 Hydroxytryptamine 3 agonist | |||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | 0.071 0.038 DBMET01456 0.073 0.034 DBMET01457 | ||
| 0.112 | 0.032 | 0.112 | Carbonic anhydrase XIII inhibitor | 0.092 0.042 DBMET01456 0.066 0.062 DBMET01457 | ||
| 0.103 | 0.023 | 0.103 | Fibroblast growth factor 2 antagonist | 0.059 0.054 DBMET01456 | ||
| 0.137 | 0.058 | 0.204 | Antibacterial (Helicobacter pylori) | 0.166 0.035 DBMET01456 0.204 0.021 DBMET01457 | DBMET01457 | |
| 0.088 | 0.009 | 0.088 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET01456 0.073 0.015 DBMET01457 | ||
| 0.226 | 0.147 | 0.226 | Antithrombotic | 0.207 0.169 DBMET01456 0.225 0.148 DBMET01457 | ||
| 0.109 | 0.031 | 0.109 | 5 Hydroxytryptamine agonist | |||
| 0.083 | 0.005 | 0.083 | Arginase inhibitor | 0.062 0.01 DBMET01456 0.044 0.019 DBMET01457 | ||
| 0.105 | 0.027 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.074 0.057 DBMET01456 0.07 0.06 DBMET01457 | ||
| 0.082 | 0.004 | 0.082 | Growth hormone release promoting | 0.061 0.005 DBMET01456 0.023 0.012 DBMET01457 | ||
| 0.103 | 0.026 | 0.103 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 DBMET01456 0.087 0.05 DBMET01457 | ||
| 0.09 | 0.013 | 0.096 | Beta 1 adrenoreceptor antagonist | 0.078 0.019 DBMET01456 0.096 0.011 DBMET01457 | DBMET01457 | |
| 0.081 | 0.005 | 0.081 | Alpha 1d adrenoreceptor agonist | |||
| 0.081 | 0.005 | 0.091 | Membrane dipeptidase inhibitor | 0.091 0.004 DBMET01456 0.08 0.005 DBMET01457 | DBMET01456 | |
| 0.092 | 0.016 | 0.092 | Interferon inducer | 0.08 0.024 DBMET01456 0.088 0.018 DBMET01457 | ||
| 0.14 | 0.065 | 0.173 | Aurora-C kinase inhibitor | 0.158 0.042 DBMET01456 0.173 0.03 DBMET01457 | DBMET01457 | |
| 0.084 | 0.009 | 0.122 | Gonadotropin-releasing hormone receptor antagonist | 0.09 0.009 DBMET01456 0.122 0.005 DBMET01457 | DBMET01457 | |
| 0.09 | 0.015 | 0.09 | Bombesin 2 receptor antagonist | 0.079 0.017 DBMET01456 0.065 0.022 DBMET01457 | ||
| 0.089 | 0.014 | 0.12 | Histone deacetylase SIRT3 inhibitor | 0.12 0.007 DBMET01456 0.11 0.008 DBMET01457 | DBMET01456 | |
| 0.079 | 0.004 | 0.079 | AMPA 3 receptor antagonist | 0.067 0.005 DBMET01456 0.046 0.011 DBMET01457 | ||
| 0.082 | 0.008 | 0.082 | Beta 2 adrenoreceptor agonist | 0.072 0.016 DBMET01456 0.076 0.012 DBMET01457 | ||
| 0.161 | 0.087 | 0.161 | CDC-like kinase 2 inhibitor | |||
| 0.161 | 0.087 | 0.161 | Tumour necrosis factor antagonist | |||
| 0.103 | 0.03 | 0.103 | NMDA 2 receptor antagonist | |||
| 0.155 | 0.082 | 0.352 | Sigma receptor agonist | 0.156 0.081 DBMET01456 0.352 0.03 DBMET01457 | DBMET01457 | |
| 0.089 | 0.018 | 0.121 | Beta 3 adrenoreceptor antagonist | 0.084 0.021 DBMET01456 0.121 0.009 DBMET01457 | DBMET01457 | |
| 0.093 | 0.023 | 0.12 | Vanilloid 4 agonist | 0.092 0.023 DBMET01456 0.12 0.007 DBMET01457 | DBMET01457 | |
| 0.118 | 0.047 | 0.118 | Urease inhibitor | 0.098 0.07 DBMET01456 0.101 0.066 DBMET01457 | ||
| 0.1 | 0.03 | 0.1 | Purinergic P2X2 antagonist | 0.058 0.053 DBMET01456 | ||
| 0.174 | 0.105 | 0.175 | Neurotrophic factor enhancer | 0.175 0.103 DBMET01457 | DBMET01457 | |
| 0.077 | 0.008 | 0.077 | Dipeptidyl peptidase IV inhibitor | 0.055 0.015 DBMET01456 0.045 0.029 DBMET01457 | ||
| 0.079 | 0.009 | 0.079 | Ryanodine receptor antagonist | 0.063 0.031 DBMET01456 0.077 0.011 DBMET01457 | ||
| 0.085 | 0.016 | 0.085 | AMPA receptor antagonist | 0.06 0.025 DBMET01456 0.047 0.034 DBMET01457 | ||
| 0.086 | 0.017 | 0.086 | Bombesin 3 receptor antagonist | 0.05 0.047 DBMET01456 | ||
| 0.139 | 0.07 | 0.139 | Toll-Like receptor 9 antagonist | |||
| 0.073 | 0.005 | 0.073 | Lysine carboxypeptidase inhibitor | 0.035 0.012 DBMET01456 0.03 0.016 DBMET01457 | ||
| 0.086 | 0.018 | 0.086 | NMDA 2A receptor antagonist | 0.053 0.035 DBMET01456 0.047 0.04 DBMET01457 | ||
| 0.1 | 0.032 | 0.1 | Fibroblast growth factor 3 antagonist | |||
| 0.089 | 0.021 | 0.107 | Protease 3C (Human rhinovirus) inhibitor | 0.101 0.015 DBMET01456 0.107 0.013 DBMET01457 | DBMET01457 | |
| 0.076 | 0.01 | 0.076 | Histamine H4 receptor antagonist | |||
| 0.075 | 0.009 | 0.075 | Phosphoglycerate kinase inhibitor | 0.043 0.017 DBMET01456 0.033 0.026 DBMET01457 | ||
| 0.071 | 0.005 | 0.071 | Bombesin 1 receptor antagonist | 0.066 0.006 DBMET01456 0.055 0.01 DBMET01457 | ||
| 0.099 | 0.033 | 0.137 | Glycine receptor antagonist | 0.101 0.031 DBMET01456 0.137 0.011 DBMET01457 | DBMET01457 | |
| 0.103 | 0.037 | 0.103 | Acetylcholine nicotinic antagonist | 0.07 0.069 DBMET01457 | ||
| 0.07 | 0.004 | 0.07 | Calcium-sensing receptor agonist | 0.049 0.005 DBMET01456 0.04 0.007 DBMET01457 | ||
| 0.081 | 0.015 | 0.081 | Sphingosine kinase 2 inhibitor | |||
| 0.126 | 0.061 | 0.126 | Beta amyloid protein antagonist | 0.116 0.072 DBMET01457 | ||
| 0.097 | 0.033 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.067 0.066 DBMET01457 | ||
| 0.077 | 0.013 | 0.083 | Beta 2 adrenoreceptor antagonist | 0.068 0.018 DBMET01456 0.083 0.011 DBMET01457 | DBMET01457 | |
| 0.066 | 0.002 | 0.073 | Purinergic P2Y15 antagonist | 0.073 0.002 DBMET01456 0.064 0.002 DBMET01457 | DBMET01456 | |
| 0.121 | 0.058 | 0.121 | Alpha 2b adrenoreceptor antagonist | 0.102 0.073 DBMET01457 | ||
| 0.141 | 0.079 | 0.185 | Thiol protease inhibitor | 0.165 0.057 DBMET01456 0.185 0.046 DBMET01457 | DBMET01457 | |
| 0.072 | 0.01 | 0.072 | Glutamate (mGluR4) antagonist | 0.045 0.028 DBMET01456 0.046 0.025 DBMET01457 | ||
| 0.083 | 0.021 | 0.083 | Plasmin inhibitor | 0.064 0.026 DBMET01456 | ||
| 0.071 | 0.009 | 0.071 | Somatostatin 5 antagonist | 0.035 0.021 DBMET01456 | ||
| 0.092 | 0.031 | 0.092 | Thrombin inhibitor | 0.076 0.047 DBMET01456 | ||
| 0.085 | 0.024 | 0.085 | Acetylcholine M3 receptor antagonist | 0.059 0.042 DBMET01456 0.062 0.039 DBMET01457 | ||
| 0.076 | 0.015 | 0.09 | Myc inhibitor | 0.067 0.022 DBMET01456 0.09 0.01 DBMET01457 | DBMET01457 | |
| 0.119 | 0.059 | 0.119 | Cystathionine beta-synthase inhibitor | |||
| 0.257 | 0.197 | 0.262 | Calcium channel L-type activator | 0.262 0.193 DBMET01457 | DBMET01457 | |
| 0.105 | 0.047 | 0.105 | Alcohol dehydrogenase inhibitor | 0.081 0.079 DBMET01457 | ||
| 0.069 | 0.012 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 DBMET01456 0.065 0.017 DBMET01457 | ||
| 0.084 | 0.027 | 0.084 | Acetylcholine M2 receptor antagonist | 0.076 0.032 DBMET01456 0.076 0.032 DBMET01457 | ||
| 0.065 | 0.008 | 0.065 | Histamine H3 receptor agonist | |||
| 0.107 | 0.052 | 0.107 | Fibroblast growth factor 1 antagonist | |||
| 0.133 | 0.078 | 0.133 | Ribosomal protein S6 kinase inhibitor | |||
| 0.096 | 0.041 | 0.129 | Glutathione S-transferase inhibitor | 0.111 0.029 DBMET01456 0.129 0.018 DBMET01457 | DBMET01457 | |
| 0.066 | 0.012 | 0.066 | Oxytocin agonist | 0.065 0.013 DBMET01456 0.064 0.014 DBMET01457 | ||
| 0.09 | 0.037 | 0.095 | CC chemokine 5 receptor agonist | 0.095 0.028 DBMET01457 | DBMET01457 | |
| 0.151 | 0.099 | 0.25 | 3C-like protease (Human coronavirus) inhibitor | 0.18 0.065 DBMET01456 0.25 0.028 DBMET01457 | DBMET01457 | |
| 0.153 | 0.1 | 0.188 | DNA methyltransferase I inhibitor | 0.188 0.076 DBMET01457 | DBMET01457 | |
| 0.099 | 0.046 | 0.099 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.096 | 0.043 | 0.096 | Neuropeptide Y antagonist | 0.095 0.044 DBMET01456 0.088 0.049 DBMET01457 | ||
| 0.085 | 0.033 | 0.085 | Neuronal nicotinic receptor antagonist | |||
| 0.066 | 0.014 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.038 DBMET01456 0.061 0.018 DBMET01457 | ||
| 0.098 | 0.047 | 0.098 | Pim-3 kinase inhibitor | |||
| 0.067 | 0.017 | 0.082 | Melanocortin antagonist | 0.082 0.013 DBMET01456 0.061 0.02 DBMET01457 | DBMET01456 | |
| 0.059 | 0.008 | 0.059 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.031 DBMET01456 0.046 0.02 DBMET01457 | ||
| 0.061 | 0.011 | 0.061 | Kainate receptor 2 antagonist | 0.045 0.018 DBMET01456 0.06 0.012 DBMET01457 | ||
| 0.061 | 0.011 | 0.061 | Dihydropteroate synthase inhibitor | 0.039 0.027 DBMET01456 0.051 0.016 DBMET01457 | ||
| 0.058 | 0.008 | 0.058 | Kainate receptor agonist | 0.044 0.023 DBMET01456 0.045 0.021 DBMET01457 | ||
| 0.067 | 0.018 | 0.073 | Topoisomerase II beta inhibitor | 0.048 0.036 DBMET01456 0.073 0.015 DBMET01457 | DBMET01457 | |
| 0.084 | 0.034 | 0.084 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.131 | 0.082 | 0.131 | Protein kinase stimulant | |||
| 0.067 | 0.019 | 0.067 | Complement C3a chemotactic receptor antagonist | 0.058 0.023 DBMET01456 0.047 0.028 DBMET01457 | ||
| 0.059 | 0.01 | 0.059 | Fumarate hydratase inhibitor | 0.042 0.017 DBMET01456 0.049 0.014 DBMET01457 | ||
| 0.088 | 0.04 | 0.088 | Keratolytic | 0.072 0.062 DBMET01456 0.078 0.051 DBMET01457 | ||
| 0.056 | 0.008 | 0.056 | Glutamate (mGluR8) agonist | 0.04 0.022 DBMET01456 0.042 0.02 DBMET01457 | ||
| 0.146 | 0.098 | 0.146 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.056 | 0.008 | 0.056 | Dipeptidyl peptidase II inhibitor | 0.046 0.01 DBMET01456 0.039 0.015 DBMET01457 | ||
| 0.062 | 0.015 | 0.078 | CC chemokine 4 receptor antagonist | 0.073 0.009 DBMET01456 0.078 0.007 DBMET01457 | DBMET01457 | |
| 0.116 | 0.068 | 0.192 | Proteasome inhibitor | 0.162 0.04 DBMET01456 0.192 0.028 DBMET01457 | DBMET01457 | |
| 0.078 | 0.03 | 0.078 | Glutamate (mGluR7) antagonist | |||
| 0.141 | 0.094 | 0.141 | Melanin inhibitor | 0.137 0.102 DBMET01457 | ||
| 0.071 | 0.024 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | 0.053 0.05 DBMET01456 0.067 0.029 DBMET01457 | ||
| 0.064 | 0.017 | 0.064 | Adenosine deaminase inhibitor | 0.047 0.033 DBMET01456 0.049 0.032 DBMET01457 | ||
| 0.07 | 0.024 | 0.07 | Kallikrein 1 inhibitor | 0.059 0.035 DBMET01456 | ||
| 0.053 | 0.007 | 0.053 | ATM kinase inhibitor | |||
| 0.081 | 0.035 | 0.135 | Sirtuin 1 inhibitor | 0.135 0.01 DBMET01456 0.13 0.011 DBMET01457 | DBMET01456 | |
| 0.091 | 0.045 | 0.091 | mTOR complex 2 inhibitor | 0.08 0.07 DBMET01457 | ||
| 0.067 | 0.021 | 0.067 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 DBMET01456 0.052 0.031 DBMET01457 | ||
| 0.094 | 0.049 | 0.094 | Bromodomain-containing protein 2 inhibitor | 0.091 0.054 DBMET01457 | ||
| 0.113 | 0.069 | 0.113 | Microtubule formation inhibitor | 0.111 0.072 DBMET01457 | ||
| 0.066 | 0.022 | 0.066 | 5 Hydroxytryptamine 2 agonist | |||
| 0.124 | 0.08 | 0.124 | Sodium channel blocker | |||
| 0.085 | 0.042 | 0.085 | Acetylcholine M4 receptor antagonist | 0.069 0.058 DBMET01457 | ||
| 0.073 | 0.029 | 0.073 | Alpha 2 adrenoreceptor agonist | |||
| 0.112 | 0.069 | 0.112 | TRPA1 agonist | 0.102 0.084 DBMET01457 | ||
| 0.067 | 0.024 | 0.069 | Protease activated receptor 1 antagonist | 0.069 0.023 DBMET01456 | DBMET01456 | |
| 0.08 | 0.038 | 0.08 | Alpha adrenoreceptor agonist | |||
| 0.058 | 0.015 | 0.058 | Cytokine production stimulant | 0.051 0.028 DBMET01456 0.054 0.02 DBMET01457 | ||
| 0.062 | 0.019 | 0.062 | Squalene epoxidase inhibitor | 0.053 0.03 DBMET01457 | ||
| 0.084 | 0.043 | 0.084 | Rho-associated kinase I inhibitor | 0.072 0.054 DBMET01456 | ||
| 0.058 | 0.016 | 0.058 | Leukotriene A4 hydrolase inhibitor | |||
| 0.103 | 0.062 | 0.103 | MAO A inhibitor | |||
| 0.071 | 0.03 | 0.071 | Aminopeptidase microsomal inhibitor | 0.059 0.04 DBMET01456 | ||
| 0.048 | 0.007 | 0.048 | Carboxypeptidase B inhibitor | 0.045 0.009 DBMET01456 0.036 0.017 DBMET01457 | ||
| 0.046 | 0.005 | 0.046 | Myristoyl transferase inhibitor | 0.032 0.011 DBMET01456 0.03 0.014 DBMET01457 | ||
| 0.064 | 0.024 | 0.064 | Antimetabolite | 0.046 0.034 DBMET01456 0.049 0.032 DBMET01457 | ||
| 0.049 | 0.009 | 0.049 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.018 DBMET01456 0.04 0.012 DBMET01457 | ||
| 0.053 | 0.013 | 0.053 | Beta adrenoreceptor agonist | 0.046 0.03 DBMET01456 0.05 0.017 DBMET01457 | ||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | |||
| 0.159 | 0.119 | 0.176 | Anticonvulsant | 0.176 0.103 DBMET01456 0.161 0.116 DBMET01457 | DBMET01456 | |
| 0.094 | 0.054 | 0.094 | Polo-like kinase-1 inhibitor | 0.086 0.07 DBMET01456 0.087 0.067 DBMET01457 | ||
| 0.067 | 0.028 | 0.067 | Sphingosine kinase inhibitor | |||
| 0.052 | 0.012 | 0.052 | 5 Hydroxytryptamine 2B agonist | |||
| 0.078 | 0.039 | 0.085 | Potassium channel (Tandem pore domain) blocker | 0.085 0.024 DBMET01457 | DBMET01457 | |
| 0.108 | 0.069 | 0.108 | GABA receptor agonist | 0.096 0.082 DBMET01456 0.105 0.071 DBMET01457 | ||
| 0.057 | 0.019 | 0.057 | Thymidylate synthase inhibitor | 0.046 0.033 DBMET01457 | ||
| 0.057 | 0.02 | 0.075 | Melanocortin 4 antagonist | 0.075 0.014 DBMET01456 0.061 0.018 DBMET01457 | DBMET01456 | |
| 0.065 | 0.027 | 0.065 | Toll-Like receptor 8 antagonist | |||
| 0.041 | 0.004 | 0.041 | KiSS-1 receptor antagonist | 0.02 0.009 DBMET01456 | ||
| 0.075 | 0.039 | 0.083 | Acetylcholine M5 receptor agonist | 0.083 0.032 DBMET01457 | DBMET01457 | |
| 0.068 | 0.032 | 0.068 | Acetylcholine M5 receptor antagonist | 0.062 0.039 DBMET01457 | ||
| 0.068 | 0.033 | 0.077 | Bombesin 1 receptor agonist | 0.068 0.033 DBMET01456 0.077 0.027 DBMET01457 | DBMET01457 | |
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.135 | 0.099 | 0.135 | MAP kinase kinase 4 inhibitor | |||
| 0.049 | 0.014 | 0.049 | Antibiotic Aminoglycoside-like | 0.037 0.024 DBMET01456 | ||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR1a) antagonist | 0.045 0.025 DBMET01456 0.049 0.021 DBMET01457 | ||
| 0.132 | 0.098 | 0.15 | Phospholipase A2 inhibitor | 0.141 0.084 DBMET01456 0.15 0.074 DBMET01457 | DBMET01457 | |
| 0.062 | 0.029 | 0.062 | Pim-2 kinase inhibitor | |||
| 0.075 | 0.042 | 0.103 | Secretase beta inhibitor | 0.087 0.028 DBMET01456 0.103 0.017 DBMET01457 | DBMET01457 | |
| 0.048 | 0.014 | 0.048 | Glutamate (mGluR3) antagonist | |||
| 0.059 | 0.026 | 0.059 | Glycine transporter 2 inhibitor | 0.052 0.029 DBMET01456 0.052 0.029 DBMET01457 | ||
| 0.043 | 0.011 | 0.134 | Melatonin receptor 1A agonist | 0.086 0.004 DBMET01456 0.134 0.003 DBMET01457 | DBMET01457 | |
| 0.064 | 0.031 | 0.064 | Cyclin A1 inhibitor | 0.063 0.032 DBMET01456 | ||
| 0.043 | 0.011 | 0.043 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.054 | 0.021 | 0.054 | Glutamate (mGluR group III) agonist | |||
| 0.058 | 0.026 | 0.058 | Carbonic anhydrase II stimulant | 0.055 0.03 DBMET01456 | ||
| 0.067 | 0.035 | 0.067 | Adenosine A1 receptor antagonist | 0.054 0.044 DBMET01456 0.053 0.045 DBMET01457 | ||
| 0.035 | 0.004 | 0.036 | Carbonic anhydrase VIII inhibitor | 0.036 0.004 DBMET01456 0.035 0.004 DBMET01457 | DBMET01456 | |
| 0.035 | 0.004 | 0.036 | Carbonic anhydrase X inhibitor | 0.036 0.004 DBMET01456 0.035 0.004 DBMET01457 | DBMET01456 | |
| 0.113 | 0.081 | 0.113 | Glutamate receptor antagonist | |||
| 0.067 | 0.035 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.063 | 0.031 | 0.063 | 5 Hydroxytryptamine 1 agonist | |||
| 0.067 | 0.035 | 0.067 | Purinergic P2X1 antagonist | 0.055 0.051 DBMET01457 | ||
| 0.134 | 0.103 | 0.153 | Interferon gamma antagonist | 0.153 0.074 DBMET01457 | DBMET01457 | |
| 0.036 | 0.005 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET01456 | ||
| 0.063 | 0.032 | 0.063 | Protein kinase C theta inhibitor | |||
| 0.077 | 0.047 | 0.077 | Adenosine A3 receptor antagonist | 0.066 0.065 DBMET01456 0.071 0.056 DBMET01457 | ||
| 0.043 | 0.013 | 0.052 | Peptide deformylase inhibitor | 0.047 0.011 DBMET01456 0.052 0.009 DBMET01457 | DBMET01457 | |
| 0.049 | 0.018 | 0.049 | Plasmepsin II inhibitor | 0.048 0.019 DBMET01456 0.043 0.025 DBMET01457 | ||
| 0.037 | 0.006 | 0.037 | Glutamate (mGluR1a) agonist | 0.023 0.014 DBMET01457 | ||
| 0.061 | 0.03 | 0.061 | 5 Hydroxytryptamine 7 agonist | |||
| 0.066 | 0.036 | 0.066 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.067 | 0.037 | 0.067 | Trypsin inhibitor | 0.058 0.052 DBMET01456 | ||
| 0.034 | 0.004 | 0.034 | Cyclin T1 inhibitor | |||
| 0.069 | 0.04 | 0.069 | Carbonic anhydrase inhibitor | 0.065 0.043 DBMET01457 | ||
| 0.054 | 0.024 | 0.059 | Bombesin antagonist | 0.059 0.019 DBMET01456 0.055 0.024 DBMET01457 | DBMET01456 | |
| 0.143 | 0.114 | 0.169 | ATPase inhibitor | 0.169 0.072 DBMET01457 | DBMET01457 | |
| 0.037 | 0.008 | 0.037 | Somatostatin 3 antagonist | |||
| 0.038 | 0.01 | 0.038 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.022 | 0.054 | AICAR transformylase inhibitor | 0.043 0.032 DBMET01456 0.054 0.019 DBMET01457 | DBMET01457 | |
| 0.119 | 0.091 | 0.119 | Protein kinase (CK1) gamma inhibitor | |||
| 0.033 | 0.006 | 0.033 | Histamine H4 receptor agonist | |||
| 0.038 | 0.01 | 0.038 | Growth hormone releasing factor antagonist | 0.027 0.014 DBMET01456 0.021 0.018 DBMET01457 | ||
| 0.048 | 0.021 | 0.051 | Neurokinin 2 agonist | 0.051 0.018 DBMET01456 0.042 0.027 DBMET01457 | DBMET01456 | |
| 0.061 | 0.034 | 0.064 | Carbonic anhydrase I inhibitor | 0.05 0.043 DBMET01456 0.064 0.032 DBMET01457 | DBMET01457 | |
| 0.087 | 0.06 | 0.087 | Opioid antagonist | 0.087 0.06 DBMET01456 0.076 0.074 DBMET01457 | ||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | 0.024 0.022 DBMET01457 | ||
| 0.063 | 0.037 | 0.116 | Neuropeptide agonist | 0.116 0.023 DBMET01456 0.093 0.028 DBMET01457 | DBMET01456 | |
| 0.085 | 0.059 | 0.096 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET01456 0.096 0.043 DBMET01457 | DBMET01457 | |
| 0.096 | 0.07 | 0.096 | Alpha 2c adrenoreceptor antagonist | |||
| 0.062 | 0.036 | 0.075 | Cathepsin L inhibitor | 0.07 0.03 DBMET01456 0.075 0.027 DBMET01457 | DBMET01457 | |
| 0.104 | 0.078 | 0.104 | Nav1.5 sodium channel blocker | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase II inhibitor | 0.06 0.035 DBMET01457 | ||
| 0.112 | 0.087 | 0.112 | Amylase inhibitor | |||
| 0.054 | 0.029 | 0.065 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET01456 0.065 0.018 DBMET01457 | DBMET01457 | |
| 0.033 | 0.009 | 0.04 | Lysophosphatidic acid receptor 1 agonist | 0.034 0.008 DBMET01456 0.04 0.005 DBMET01457 | DBMET01457 | |
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | 0.031 0.027 DBMET01457 | ||
| 0.12 | 0.096 | 0.12 | Activin receptor-like kinase 2 inhibitor | |||
| 0.055 | 0.03 | 0.055 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.063 | 0.038 | 0.063 | Cyclin D1 inhibitor | 0.062 0.039 DBMET01457 | ||
| 0.033 | 0.009 | 0.033 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.06 | 0.036 | 0.06 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.06 | 0.036 | 0.06 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | 0.026 0.016 DBMET01457 | ||
| 0.028 | 0.005 | 0.03 | Toll-Like receptor 8 agonist | 0.03 0.005 DBMET01456 0.023 0.009 DBMET01457 | DBMET01456 | |
| 0.047 | 0.024 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.028 | 0.005 | 0.028 | Alpha 2a adrenoreceptor agonist | |||
| 0.049 | 0.026 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.036 | 0.014 | 0.036 | Uridine phosphorylase inhibitor | |||
| 0.092 | 0.069 | 0.152 | Interleukin 1 beta converting enzyme inhibitor | 0.118 0.037 DBMET01456 0.152 0.016 DBMET01457 | DBMET01457 | |
| 0.034 | 0.012 | 0.034 | 5 Hydroxytryptamine 6 agonist | |||
| 0.061 | 0.039 | 0.061 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.043 | 0.021 | 0.051 | Factor XIIIa inhibitor | 0.046 0.018 DBMET01456 0.051 0.015 DBMET01457 | DBMET01457 | |
| 0.052 | 0.03 | 0.052 | Aminopeptidase N inhibitor | 0.042 0.039 DBMET01456 | ||
| 0.037 | 0.015 | 0.037 | 5 Hydroxytryptamine 1D agonist | |||
| 0.046 | 0.024 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET01457 | ||
| 0.043 | 0.021 | 0.043 | Carbonic anhydrase I stimulant | 0.038 0.025 DBMET01456 | ||
| 0.113 | 0.092 | 0.113 | Sodium channel (voltage-gated) blocker | |||
| 0.027 | 0.006 | 0.041 | Neuraminidase (Influenza B) inhibitor | 0.038 0.003 DBMET01456 0.041 0.003 DBMET01457 | DBMET01457 | |
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | |||
| 0.041 | 0.021 | 0.05 | Growth hormone secretagogue receptor antagonist | 0.05 0.018 DBMET01456 | DBMET01456 | |
| 0.041 | 0.021 | 0.044 | Delayed rectifier potassium channel blocker | 0.044 0.016 DBMET01457 | DBMET01457 | |
| 0.03 | 0.01 | 0.03 | Glutamate (mGluR1) agonist | 0.023 0.02 DBMET01457 | ||
| 0.024 | 0.004 | 0.024 | Prokineticin receptor 1 antagonist | |||
| 0.034 | 0.014 | 0.034 | Thrombin receptor antagonist | 0.034 0.014 DBMET01456 0.03 0.017 DBMET01457 | ||
| 0.044 | 0.024 | 0.044 | Thymidine kinase inhibitor | 0.04 0.029 DBMET01457 | ||
| 0.024 | 0.005 | 0.024 | Antibiotic Anthracycline-like | 0.02 0.011 DBMET01456 0.022 0.008 DBMET01457 | ||
| 0.039 | 0.02 | 0.047 | Calcitonin receptor agonist | 0.047 0.017 DBMET01456 0.045 0.018 DBMET01457 | DBMET01456 | |
| 0.055 | 0.036 | 0.055 | Lysine-specific demethylase 1A inhibitor | |||
| 0.043 | 0.024 | 0.051 | Cathepsin L1 inhibitor | 0.047 0.021 DBMET01456 0.051 0.019 DBMET01457 | DBMET01457 | |
| 0.027 | 0.008 | 0.027 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.048 | 0.03 | 0.048 | Carbonic anhydrase VII inhibitor | 0.044 0.035 DBMET01456 0.048 0.03 DBMET01457 | ||
| 0.059 | 0.042 | 0.059 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.089 | 0.071 | 0.097 | Butyrylcholinesterase inhibitor | 0.097 0.064 DBMET01457 | DBMET01457 | |
| 0.041 | 0.024 | 0.054 | Melanocortin 1 antagonist | 0.054 0.018 DBMET01456 0.05 0.02 DBMET01457 | DBMET01456 | |
| 0.07 | 0.053 | 0.074 | Cathepsin G inhibitor | 0.065 0.06 DBMET01456 0.074 0.049 DBMET01457 | DBMET01457 | |
| 0.041 | 0.024 | 0.041 | Factor VIIa inhibitor | |||
| 0.031 | 0.014 | 0.032 | Vasopressin 1A agonist | 0.032 0.013 DBMET01456 0.029 0.02 DBMET01457 | DBMET01456 | |
| 0.044 | 0.027 | 0.044 | Guanylate cyclase inhibitor | |||
| 0.022 | 0.006 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET01456 0.025 0.004 DBMET01457 | DBMET01457 | |
| 0.024 | 0.008 | 0.024 | Aminopeptidase A inhibitor | 0.021 0.01 DBMET01456 0.016 0.014 DBMET01457 | ||
| 0.065 | 0.05 | 0.065 | CDC7 inhibitor | |||
| 0.056 | 0.041 | 0.056 | Alpha 1 adrenoreceptor agonist | |||
| 0.063 | 0.048 | 0.088 | Histone deacetylase inhibitor | 0.077 0.034 DBMET01456 0.088 0.024 DBMET01457 | DBMET01457 | |
| 0.031 | 0.016 | 0.031 | MAP3K8 inhibitor | |||
| 0.031 | 0.016 | 0.031 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.037 | 0.023 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 DBMET01457 | ||
| 0.031 | 0.017 | 0.031 | CDK4/cyclin D3 inhibitor | |||
| 0.028 | 0.014 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET01456 | ||
| 0.068 | 0.055 | 0.073 | Calcium channel L-type blocker | 0.073 0.047 DBMET01457 | DBMET01457 | |
| 0.088 | 0.075 | 0.088 | Protein kinase (CK2) inhibitor | |||
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | 0.04 0.036 DBMET01457 | ||
| 0.151 | 0.138 | 0.158 | Histone acetyltransferase inhibitor | 0.158 0.129 DBMET01457 | DBMET01457 | |
| 0.021 | 0.009 | 0.021 | Somatostatin 3 agonist | |||
| 0.055 | 0.043 | 0.055 | Plasminogen activator inhibitor | |||
| 0.094 | 0.082 | 0.094 | Protein kinase (CK2) alpha inhibitor | |||
| 0.043 | 0.031 | 0.043 | NMDA receptor subunit 3B antagonist | |||
| 0.028 | 0.017 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.016 DBMET01456 0.028 0.017 DBMET01457 | DBMET01456 | |
| 0.043 | 0.032 | 0.043 | Sphingosine 1-phosphate receptor agonist | |||
| 0.018 | 0.007 | 0.018 | CXC chemokine 4 receptor agonist | 0.016 0.009 DBMET01456 0.014 0.012 DBMET01457 | ||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | 0.027 0.021 DBMET01457 | ||
| 0.035 | 0.024 | 0.035 | Adenosine uptake inhibitor | 0.033 0.032 DBMET01457 | ||
| 0.02 | 0.009 | 0.02 | Complement factor D inhibitor | |||
| 0.019 | 0.008 | 0.019 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET01456 0.017 0.01 DBMET01457 | ||
| 0.019 | 0.008 | 0.019 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET01456 0.015 0.011 DBMET01457 | ||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.018 | 0.007 | 0.018 | Somatostatin 2 agonist | |||
| 0.117 | 0.106 | 0.117 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.017 | 0.007 | 0.017 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 DBMET01457 | ||
| 0.019 | 0.009 | 0.019 | Telomerase stimulant | |||
| 0.024 | 0.014 | 0.024 | Beta 1 adrenoreceptor agonist | |||
| 0.027 | 0.017 | 0.027 | Melanocortin 5 antagonist | 0.026 0.018 DBMET01456 | ||
| 0.051 | 0.042 | 0.076 | Ribonucleotide reductase inhibitor | 0.075 0.029 DBMET01456 0.076 0.028 DBMET01457 | DBMET01457 | |
| 0.08 | 0.071 | 0.08 | Vanilloid agonist | 0.079 0.073 DBMET01456 | ||
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.032 | 0.023 | 0.039 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.025 DBMET01456 0.039 0.013 DBMET01457 | DBMET01457 | |
| 0.051 | 0.042 | 0.064 | Nicotinic alpha3beta2 receptor antagonist | 0.064 0.022 DBMET01457 | DBMET01457 | |
| 0.032 | 0.024 | 0.059 | Sirtuin 2 inhibitor | 0.059 0.01 DBMET01456 0.055 0.011 DBMET01457 | DBMET01456 | |
| 0.03 | 0.021 | 0.03 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.042 | 0.033 | 0.042 | Dopamine D2 agonist | |||
| 0.023 | 0.015 | 0.026 | ICAM 1 antagonist | 0.023 0.014 DBMET01456 0.026 0.01 DBMET01457 | DBMET01457 | |
| 0.021 | 0.013 | 0.021 | Factor XIII inhibitor | 0.019 0.018 DBMET01457 | ||
| 0.027 | 0.019 | 0.027 | Urotensin II agonist | |||
| 0.015 | 0.007 | 0.015 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DBMET01456 0.014 0.007 DBMET01457 | ||
| 0.052 | 0.044 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.043 DBMET01457 | ||
| 0.198 | 0.19 | 0.407 | Calpain 2 inhibitor | 0.278 0.129 DBMET01456 0.407 0.058 DBMET01457 | DBMET01457 | |
| 0.075 | 0.067 | 0.075 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.025 | 0.017 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.017 | 0.009 | 0.017 | CDK2/cyclin A3 inhibitor | 0.016 0.011 DBMET01457 | ||
| 0.024 | 0.017 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 DBMET01457 | ||
| 0.014 | 0.006 | 0.014 | Carboxypeptidase B2 inhibitor | 0.011 0.008 DBMET01456 | ||
| 0.04 | 0.032 | 0.04 | Sphingosine kinase 1 inhibitor | |||
| 0.03 | 0.023 | 0.057 | Epoxide hydrolase 1 inhibitor | 0.038 0.013 DBMET01456 0.057 0.005 DBMET01457 | DBMET01457 | |
| 0.126 | 0.118 | 0.126 | MAP kinase 3 inhibitor | |||
| 0.05 | 0.043 | 0.05 | Maillard reaction inhibitor | 0.049 0.045 DBMET01456 | ||
| 0.046 | 0.04 | 0.07 | HCV NS3/NS4A protease inhibitor | 0.058 0.023 DBMET01456 0.07 0.015 DBMET01457 | DBMET01457 | |
| 0.036 | 0.03 | 0.036 | TRPM8 blocker | |||
| 0.028 | 0.022 | 0.028 | Factor VII inhibitor | |||
| 0.022 | 0.016 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET01457 | ||
| 0.067 | 0.061 | 0.067 | Alpha 2a adrenoreceptor antagonist | |||
| 0.015 | 0.01 | 0.015 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.052 | 0.047 | 0.052 | Dopamine uptake inhibitor | |||
| 0.012 | 0.008 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.047 | 0.043 | 0.075 | Ribonucleoside-diphosphate reductase inhibitor | 0.07 0.029 DBMET01456 0.075 0.027 DBMET01457 | DBMET01457 | |
| 0.024 | 0.02 | 0.024 | Sigma 2 receptor antagonist | |||
| 0.058 | 0.054 | 0.067 | Neutrophil collagenase inhibitor | 0.063 0.048 DBMET01456 0.067 0.043 DBMET01457 | DBMET01457 | |
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.017 | 0.013 | 0.017 | Sodium/hydrogen exchanger inhibitor | |||
| 0.015 | 0.011 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.053 | 0.049 | 0.087 | Cannabinoid CB1 receptor agonist | 0.057 0.045 DBMET01456 0.087 0.025 DBMET01457 | DBMET01457 | |
| 0.049 | 0.046 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.013 | 0.01 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 DBMET01456 0.02 0.004 DBMET01457 | DBMET01457 | |
| 0.026 | 0.023 | 0.026 | Glucosylceramidase stimulant | |||
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.086 | 0.084 | 0.122 | Gastric antisecretory | 0.122 0.041 DBMET01457 | DBMET01457 | |
| 0.123 | 0.122 | 0.123 | Heat shock protein 90 alpha antagonist | |||
| 0.035 | 0.034 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET01457 | DBMET01457 | |
| 0.053 | 0.052 | 0.056 | Pregnane X receptor antagonist | 0.056 0.041 DBMET01457 | DBMET01457 | |
| 0.015 | 0.015 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET01457 | DBMET01457 | |
| 0.017 | 0.017 | 0.022 | Neurokinin 1 agonist | 0.022 0.013 DBMET01456 0.02 0.014 DBMET01457 | DBMET01456 | |
| 0.054 | 0.055 | 0.067 | Gonadotropin-releasing hormone receptor agonist | 0.061 0.037 DBMET01456 0.067 0.029 DBMET01457 | DBMET01457 | |
| 0.025 | 0.026 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET01457 | DBMET01457 | |
| 0.05 | 0.051 | 0.059 | Dihydroorotate oxidase inhibitor | 0.059 0.031 DBMET01457 | DBMET01457 | |
| 0.019 | 0.021 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET01457 | DBMET01457 | |
| 0.016 | 0.019 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.01 DBMET01457 | DBMET01457 | |
| 0.034 | 0.039 | 0.06 | Histone deacetylase 9 inhibitor | 0.037 0.032 DBMET01456 0.06 0.012 DBMET01457 | DBMET01457 | |
| 0.018 | 0.023 | 0.049 | Protease (Human cytomegalovirus) inhibitor | 0.027 0.01 DBMET01456 0.049 0.004 DBMET01457 | DBMET01457 | |
| 0.048 | 0.054 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.047 DBMET01456 | DBMET01456 | |
| 0.01 | 0.018 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.011 DBMET01457 | DBMET01457 | |
| 0.007 | 0.018 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.006 DBMET01457 | DBMET01457 | |
| 0.039 | 0.05 | 0.044 | Adenosine A2b receptor antagonist | 0.044 0.042 DBMET01457 | DBMET01457 | |
| 0.042 | 0.053 | 0.061 | Prolyl endopeptidase inhibitor | 0.061 0.023 DBMET01457 | DBMET01457 | |
| 0.042 | 0.055 | 0.047 | Potassium channel (Inward rectifier) activator | 0.047 0.043 DBMET01457 | DBMET01457 | |
| 0.041 | 0.054 | 0.045 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 DBMET01457 | DBMET01457 | |
| 0.101 | 0.115 | 0.11 | Calcium channel blocker | 0.11 0.1 DBMET01457 | DBMET01457 | |
| 0.008 | 0.023 | 0.028 | Melatonin 2 antagonist | 0.015 0.005 DBMET01456 0.028 0.003 DBMET01457 | DBMET01457 | |
| 0.029 | 0.044 | 0.04 | Histone deacetylase class I inhibitor | 0.04 0.027 DBMET01457 | DBMET01457 | |
| 0.018 | 0.033 | 0.031 | Bradykinin B2 receptor antagonist | 0.031 0.022 DBMET01456 0.027 0.024 DBMET01457 | DBMET01456 | |
| 0.06 | 0.076 | 0.065 | MDM2 inhibitor | 0.065 0.054 DBMET01457 | DBMET01457 | |
| 0.036 | 0.052 | 0.117 | Neuraminidase (Influenza A) inhibitor | 0.106 0.004 DBMET01456 0.117 0.004 DBMET01457 | DBMET01457 | |
| 0.091 | 0.107 | 0.147 | Caspase 3 inhibitor | 0.112 0.072 DBMET01456 0.147 0.03 DBMET01457 | DBMET01457 | |
| 0.027 | 0.044 | 0.065 | Histone deacetylase 7 inhibitor | 0.065 0.014 DBMET01457 | DBMET01457 | |
| 0.042 | 0.06 | 0.053 | CD45 antagonist | 0.046 0.045 DBMET01456 0.053 0.029 DBMET01457 | DBMET01457 | |
| 0.057 | 0.078 | 0.092 | Epoxide hydrolase inhibitor | 0.092 0.031 DBMET01457 | DBMET01457 | |
| 0.13 | 0.151 | 0.139 | Non-steroidal antiinflammatory agent | 0.139 0.133 DBMET01457 | DBMET01457 | |
| 0.011 | 0.032 | 0.025 | Melanocortin 3 antagonist | 0.025 0.022 DBMET01456 | DBMET01456 | |
| 0.043 | 0.066 | 0.054 | Vanilloid 2 antagonist | 0.054 0.033 DBMET01457 | DBMET01457 | |
| 0.045 | 0.068 | 0.085 | Selectin antagonist | 0.08 0.037 DBMET01456 0.085 0.034 DBMET01457 | DBMET01457 | |
| 0.008 | 0.032 | 0.049 | Melatonin receptor 1A antagonist | 0.017 0.007 DBMET01456 0.049 0.004 DBMET01457 | DBMET01457 | |
| 0.011 | 0.037 | 0.028 | Melanocortin agonist | 0.028 0.018 DBMET01456 0.023 0.019 DBMET01457 | DBMET01456 | |
| 0.117 | 0.142 | 0.129 | Pregnane X receptor agonist | 0.129 0.102 DBMET01457 | DBMET01457 | |
| 0.009 | 0.035 | 0.084 | Melatonin 3 antagonist | 0.047 0.006 DBMET01456 0.084 0.005 DBMET01457 | DBMET01457 | |
| 0.011 | 0.037 | 0.023 | Melanocortin 4 agonist | 0.023 0.018 DBMET01456 0.02 0.019 DBMET01457 | DBMET01456 | |
| 0.188 | 0.217 | 0.225 | Ca(v)3.3 blocker | 0.225 0.142 DBMET01457 | DBMET01457 | |
| 0.013 | 0.044 | 0.02 | Caspase 8 inhibitor | 0.02 0.012 DBMET01457 | DBMET01457 | |
| 0.025 | 0.056 | 0.039 | Growth factor receptor-bound protein 2 antagonist | 0.038 0.018 DBMET01456 0.039 0.016 DBMET01457 | DBMET01457 | |
| 0.007 | 0.039 | 0.024 | Melanocortin 1 agonist | 0.022 0.019 DBMET01456 0.024 0.019 DBMET01457 | DBMET01457 | |
| 0.04 | 0.072 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.045 DBMET01457 | DBMET01457 | |
| 0.004 | 0.037 | 0.02 | Melanocortin 5 agonist | 0.02 0.016 DBMET01456 0.018 0.016 DBMET01457 | DBMET01456 | |
| 0.057 | 0.092 | 0.073 | Metalloproteinase-9 inhibitor | 0.073 0.051 DBMET01457 | DBMET01457 | |
| 0.02 | 0.055 | 0.734 | Melatonin 2 agonist | 0.433 0.003 DBMET01456 0.734 0.002 DBMET01457 | DBMET01457 | |
| 0.04 | 0.076 | 0.053 | Heparanase inhibitor | 0.053 0.037 DBMET01457 | DBMET01457 | |
| 0.106 | 0.143 | 0.137 | Hexokinase inhibitor | 0.137 0.095 DBMET01457 | DBMET01457 | |
| 0.137 | 0.177 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 DBMET01457 | DBMET01457 | |
| 0.038 | 0.078 | 0.049 | CC chemokine 2 receptor antagonist | 0.049 0.047 DBMET01457 | DBMET01457 | |
| 0.029 | 0.069 | 0.043 | Potassium channel Kv1.3 blocker | 0.043 0.037 DBMET01457 | DBMET01457 | |
| 0.024 | 0.065 | 0.044 | Erythropoietin receptor agonist | 0.044 0.025 DBMET01456 0.044 0.025 DBMET01457 | DBMET01457 | |
| 0.044 | 0.085 | 0.063 | Nitric oxide donor | 0.063 0.043 DBMET01456 0.059 0.05 DBMET01457 | DBMET01456 | |
| 0.165 | 0.21 | 0.198 | Immunomodulator | 0.198 0.166 DBMET01456 | DBMET01456 | |
| 0.019 | 0.069 | 0.721 | Melatonin 1 agonist | 0.355 0.003 DBMET01456 0.721 0.002 DBMET01457 | DBMET01457 | |
| 0.053 | 0.104 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.061 DBMET01457 | DBMET01457 | |
| 0.015 | 0.068 | 0.029 | Cathepsin K inhibitor | 0.029 0.016 DBMET01457 | DBMET01457 | |
| 0.017 | 0.073 | 0.035 | Calpain 1 inhibitor | 0.035 0.019 DBMET01457 | DBMET01457 | |
| 0.061 | 0.122 | 0.085 | Caspase 7 inhibitor | 0.085 0.05 DBMET01457 | DBMET01457 | |
| 0.024 | 0.091 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET01457 | DBMET01457 | |
| 0.043 | 0.11 | 0.123 | Histone deacetylase SIRT2 inhibitor | 0.123 0.014 DBMET01456 0.12 0.016 DBMET01457 | DBMET01456 | |
| 0.031 | 0.099 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 DBMET01457 | DBMET01457 | |
| 0.042 | 0.111 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.049 DBMET01457 | DBMET01457 | |
| 0.077 | 0.147 | 0.109 | Calcium channel N-type blocker | 0.109 0.08 DBMET01457 | DBMET01457 | |
| 0.022 | 0.095 | 0.045 | Stearoyl-CoA desaturase inhibitor | 0.045 0.029 DBMET01457 | DBMET01457 | |
| 0.041 | 0.114 | 0.071 | Amidase inhibitor | 0.071 0.048 DBMET01457 | DBMET01457 | |
| 0.165 | 0.242 | 0.303 | Apoptosis antagonist | 0.289 0.093 DBMET01456 0.303 0.083 DBMET01457 | DBMET01457 | |
| 0.083 | 0.162 | 0.12 | Cytidine deaminase inhibitor | 0.12 0.101 DBMET01457 | DBMET01457 | |
| 0.028 | 0.108 | 0.055 | Cannabinoid receptor agonist | 0.055 0.053 DBMET01457 | DBMET01457 | |
| 0.015 | 0.097 | 0.699 | Melatonin agonist | 0.328 0.003 DBMET01456 0.699 0.002 DBMET01457 | DBMET01457 | |
| 0.054 | 0.139 | 0.09 | Mediator release inhibitor | 0.09 0.082 DBMET01457 | DBMET01457 | |
| 0.054 | 0.139 | 0.119 | Protease inhibitor | 0.102 0.064 DBMET01456 0.119 0.048 DBMET01457 | DBMET01457 | |
| 0.033 | 0.122 | 0.071 | Cathepsin B inhibitor | 0.054 0.042 DBMET01456 0.071 0.028 DBMET01457 | DBMET01457 | |
| 0.064 | 0.17 | 0.123 | Bone formation stimulant | 0.111 0.095 DBMET01456 0.123 0.083 DBMET01457 | DBMET01457 | |
| 0.092 | 0.205 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.057 DBMET01456 0.149 0.035 DBMET01457 | DBMET01457 | |
| 0.005 | 0.125 | 0.021 | Human T-cell leukemia virus type I protease inhibitor | 0.021 0.015 DBMET01457 | DBMET01457 | |
| 0.008 | 0.137 | 0.594 | Melatonin antagonist | 0.251 0.003 DBMET01456 0.594 0.003 DBMET01457 | DBMET01457 | |
| 0.023 | 0.16 | 0.065 | Human rhinovirus A protease inhibitor | 0.058 0.036 DBMET01456 0.065 0.031 DBMET01457 | DBMET01457 | |
| 0.024 | 0.169 | 0.111 | Cathepsin D inhibitor | 0.07 0.029 DBMET01456 0.111 0.015 DBMET01457 | DBMET01457 | |
| 0.115 | 0.273 | 0.187 | 12-Lipoxygenase inhibitor | 0.187 0.166 DBMET01457 | DBMET01457 | |
| 0.006 | 0.17 | 0.56 | Melatonin 1 antagonist | 0.186 0.003 DBMET01456 0.56 0.002 DBMET01457 | DBMET01457 | |
| 0.022 | 0.197 | 0.041 | Cathepsin F inhibitor | 0.041 0.031 DBMET01457 | DBMET01457 | |
| 0.018 | 0.199 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET01457 | DBMET01457 | |
| 0.008 | 0.193 | 0.068 | Caspase 2 inhibitor | 0.043 0.014 DBMET01456 0.068 0.008 DBMET01457 | DBMET01457 | |
| 0.015 | 0.201 | 0.178 | Neuraminidase inhibitor | 0.157 0.005 DBMET01456 0.178 0.005 DBMET01457 | DBMET01457 | |
| 0.03 | 0.226 | 0.068 | DNA helicase inhibitor | 0.068 0.019 DBMET01457 | DBMET01457 | |
| 0.121 | 0.322 | 0.267 | Antiobesity | 0.267 0.142 DBMET01457 | DBMET01457 | |
| 0.02 | 0.238 | 0.185 | Neuraminidase (influenza) inhibitor | 0.16 0.006 DBMET01456 0.185 0.005 DBMET01457 | DBMET01457 | |
| 0.029 | 0.263 | 0.055 | Cathepsin E inhibitor | 0.055 0.048 DBMET01457 | DBMET01457 | |
| 0.008 | 0.316 | 0.045 | Cathepsin L2 inhibitor | 0.045 0.025 DBMET01457 | DBMET01457 | |
| 0.016 | 0.337 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 DBMET01457 | DBMET01457 | |
| 0.029 | 0.387 | 0.115 | Lipid peroxidase inhibitor | 0.115 0.099 DBMET01457 | DBMET01457 | |
| 0.043 | 0.41 | 0.106 | CDK3/cyclin E inhibitor | 0.106 0.076 DBMET01457 | DBMET01457 | |
| 0.03 | 0.406 | 0.086 | Falcipain inhibitor | 0.086 0.067 DBMET01457 | DBMET01457 | |
| 0.028 | 0.521 | 0.09 | Nav1.1 sodium channel blocker | 0.09 0.08 DBMET01457 | DBMET01457 | |
| 0.052 | 0.623 | 0.344 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 DBMET01456 0.344 0.043 DBMET01457 | DBMET01457 | |
| 0.004 | 0.645 | 0.03 | Acetyl-CoA carboxylase 1 inhibitor | 0.03 0.008 DBMET01457 | DBMET01457 | |
| 0.025 | 0.689 | 0.107 | 3C-Like protease (SARS coronavirus) inhibitor | 0.084 0.059 DBMET01456 0.107 0.027 DBMET01457 | DBMET01457 | |
| 0.003 | 0.683 | 0.09 | Acetyl-CoA carboxylase 2 inhibitor | 0.05 0.007 DBMET01456 0.09 0.004 DBMET01457 | DBMET01457 | |
| 0.005 | 0.812 | 0.118 | Acetyl-CoA carboxylase inhibitor | 0.079 0.008 DBMET01456 0.118 0.004 DBMET01457 | DBMET01457 | |
| 0.004 | 0.834 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.028 DBMET01457 | DBMET01457 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |